Relation between sex hormone binding globulin and D-norgestrel levels in plasma
- PMID: 578629
- DOI: 10.1530/acta.0.0860430
Relation between sex hormone binding globulin and D-norgestrel levels in plasma
Abstract
In order to investigate the effect of changes in sex hormone binding globulin (SHBG) levels on d-norgestrel (d-Ng) levels in plasma, the plasma levels of SHBG and d-Ng were studied during one treatment cycle in 6 women on oral contraceptives containing d-Ng and ethinyloestradiol (EOE2) and in 3 women using subcutaneous silastic rods containing d-Ng concomitantly taking EOe2 for three weeks. A significant positive correlation between the SHBG and d-Ng levels was found in 7 of the 9 subjects studied. The results provide evidence for an in vivo binding of d-Ng to SHBG, a SHBG influence on the metabolic clearance rate of d-Ng and consequently a dependence of the plasma levels of d-Ng on the SHBG concentrations in the plasma. These findings support the concept that the clinically and biochemically observed anti-oestrogenic/androgenic effects observed in women on d-Ng containing medication are due to a displacement of testosterone from SHBG by d-Ng.
Similar articles
-
Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.Ann Clin Biochem. 1981 Jul;18(Pt 4):226-31. doi: 10.1177/000456328101800407. Ann Clin Biochem. 1981. PMID: 7197136
-
Changes in unbound sex steroids and sex hormone binding globulin--binding capacity during oral and vaginal progestogen administration.Am J Obstet Gynecol. 1982 Nov 1;144(5):578-84. doi: 10.1016/0002-9378(82)90231-9. Am J Obstet Gynecol. 1982. PMID: 6890312
-
Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.Fertil Steril. 1984 Jul;42(1):44-51. doi: 10.1016/s0015-0282(16)47956-2. Fertil Steril. 1984. PMID: 6233179
-
Hormonal and nonhormonal factors affecting sex hormone-binding globulin levels in blood.Ann N Y Acad Sci. 1988;538:280-6. doi: 10.1111/j.1749-6632.1988.tb48872.x. Ann N Y Acad Sci. 1988. PMID: 3056190 Review.
-
Long-term profile of a new progestin.Int J Fertil. 1992;37 Suppl 4:218-22. Int J Fertil. 1992. PMID: 1362189 Review.
Cited by
-
[Concerning an implantable contraceptive: a memorandum of a WHO meeting].Bull World Health Organ. 1985;63(5):859-68. Bull World Health Organ. 1985. PMID: 3937610 Free PMC article. No abstract available.
-
Facts about an implantable contraceptive: memorandum from a WHO meeting.Bull World Health Organ. 1985;63(3):485-94. Bull World Health Organ. 1985. PMID: 3930082 Free PMC article.
-
Metabolism of a new synthetic progestagen, Org 2969, in female volunteers. Pharmacokinetics after an oral dose.Eur J Clin Pharmacol. 1979 Jun 12;15(5):349-55. doi: 10.1007/BF00558439. Eur J Clin Pharmacol. 1979. PMID: 456407 No abstract available.
-
Free plasma testosterone levels during the normal menstrual cycle.J Endocrinol Invest. 1985 Oct;8(5):437-41. doi: 10.1007/BF03348533. J Endocrinol Invest. 1985. PMID: 4078242
-
Clinical pharmacokinetics of oral contraceptive steroids.Clin Pharmacokinet. 1983 Mar-Apr;8(2):95-136. doi: 10.2165/00003088-198308020-00001. Clin Pharmacokinet. 1983. PMID: 6342899 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Miscellaneous